Kenya's national antimicrobial consumption data spans 2020 to 2024, sourced from import permits and standardized using the WHO ATC/DDD Index 2025. Hospital-level data covers January 2024 to April 2025 from 10 facilities, including national, county, and private referral hospitals. Consumption is measured in defined daily doses per 1,000 inhabitants per day.
Use Cases
- Analyze trends in national antimicrobial consumption from 2020 to 2024 using defined daily doses per 1,000 inhabitants per day.
- Compare antimicrobial use patterns across different hospital types (national referral, county referral, private) for the period January 2024 to April 2025.
- Correlate pharmacy board import permit data with hospital-level consumption data to assess supply chain efficiency.
- Benchmark Kenya's antimicrobial consumption against WHO ATC/DDD Index 2025 standards.
Strengths
- National data covers a 5-year period from 2020 to 2024.
- Hospital-level data includes 10 distinct facilities across different tiers of care.
Limitations
- Hospital-level data covers only a 16-month period (January 2024 to April 2025), limiting long-term trend analysis.
- Data is limited to 10 facilities, which may not be fully representative of all hospitals in Kenya.
- Specific row counts, column details, and sample sizes are unknown.
Provenance
- Source
- Pharmacy and Poisons Board import/donation permits and 10 selected hospitals.
- Collection Method
- National data sourced from regulatory permits; hospital data collected from facility records. Consumption standardized using WHO ATC/DDD Index 2025.
- Time Range
- National: 2020-2024. Hospital: January 2024 - April 2025.
- Freshness
- Data includes records up to April 2025 and was last updated in April 2026.
- Geography
- Kenya (national level and 10 specific hospital facilities).